investorscraft@gmail.com

Stock Analysis & ValuationDecoy Therapeutics Inc. (DCOY)

Previous Close
$5.90
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)n/a
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

One Broadway
Cambridge, MA 02142
United States
Industry: Biotechnology
Sector: Healthcare
CEO: Frederick E. Pierce
Full Time Employees: 2

Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company is headquartered in Cambridge, MA.

HomeMenuAccount